Newfound Research’s Exelon EXC Stock Holding History

Newfound Research’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-97	Closed	-$3K	–	92
2020 Q1	$3K	Hold	97	–	–	﹤0.01%	30
2019 Q4	$3K	Sell	97 -45	-32%	-$1.46K	﹤0.01%	72
2019 Q3	$5K	Buy	142 +9	+7%	+$302	﹤0.01%	67
2019 Q2	$5K	Buy	133 +8	+6%	+$282	﹤0.01%	63
2019 Q1	$4K	Buy	125 +10	+9%	+$341	﹤0.01%	60
2018 Q4	$4K	Buy	115 +6	+6%	+$192	﹤0.01%	39
2018 Q3	$3K	Buy	109 +2	+2%	+$62	﹤0.01%	93
2018 Q2	$3K	Buy	107 +10	+10%	+$286	﹤0.01%	78
2018 Q1	$3K	Sell	97 -17	-15%	-$459	﹤0.01%	78
2017 Q4	$3K	Buy	114 +2	+2%	+$57	﹤0.01%	90
2017 Q3	$3K	Buy	112 +1	+0.9%	+$27	﹤0.01%	77
2017 Q2	$3K	Buy	111 +2	+2%	+$51	﹤0.01%	85
2017 Q1	$3K	Buy	109 +5	+5%	+$127	﹤0.01%	83
2016 Q4	$3K	Buy	104 +4	+4%	+$95	﹤0.01%	71
2016 Q3	$2K	Buy	100 +6	+6%	+$151	﹤0.01%	88
2016 Q2	$2K	Buy	+94	New	+$2.33K	﹤0.01%	82

Other funds holding EXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Newfound Research's EXC Position: Q2 2020 in Review

Newfound Research sold out of Exelon (EXC) in Q2 2020, closing a stake of 97 shares — an estimated $3K sold.

Newfound Research first reported a position in EXC in Q2 2016 and held it in 16 quarters. The position peaked at $5K in Q3 2019. 877 funds tracked by Wall St. Rank hold EXC as of Q2 2020.

Newfound Research reported no remaining Exelon position as of Q2 2020 after selling out during the quarter.
Newfound Research sold 97 Exelon shares in Q2 2020, an estimated $3K.
Newfound Research first reported a position in Exelon in Q2 2016 and held it in 16 quarters.
Newfound Research's Exelon position peaked at $5K in Q3 2019.
877 funds tracked by Wall St. Rank held Exelon as of Q2 2020.

Based on Newfound Research's 13F filing for Q2 2020, filed 10 Aug 2020.